Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692049016 | Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3692050016 | Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692052012 | Danthron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Is a | Dantron- and poloxamer 188-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has precise active ingredient | Dantron | true | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has precise active ingredient | Poloxamer 188 (substance) | true | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has basis of strength substance (attribute) | Dantron | true | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has basis of strength substance (attribute) | Poloxamer 188 (substance) | true | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength numerator value | 200 | false | Inferred relationship | Some | 2 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Has concentration strength numerator value | 15 | false | Inferred relationship | Some | 1 | |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Plays role | Laxative therapeutic role | false | Inferred relationship | Some | ||
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Plays role | Stool softener therapeutic role | false | Inferred relationship | Some | ||
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension | Is a | Dantron and poloxamer 188 only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR